European Archives - Page 173 of 1113 - European Medical Journal

stamp of approval

FDA approves first gene therapy delivered directly to the brain

Discover how PTC Therapeutics’ treatment for a rare and fatal genetic disorder called aromatic l-amino acid decarboxylase (AADC) deficiency reached approval

Stress on Schedule: Gut Bacteria Found to Regulate Stress Responsivity

The natural oscillations of gut microbes influence stress hormone release and stress-sensitive behaviours at different times of day.

AI at the Heart of Medicine

This week, Jonathan is joined by Chris McIntosh, to discuss the advancement of AI from “bench-to-bedside”, while considering concerns around bias and fairness when working with diverse patient populations.

Underdiagnosed HFpEF in Severe Isolated Tricuspid Regurgitation

A recent study reveals that heart failure with preserved ejection fraction is significantly underdiagnosed in patients with severe isolated tricuspid regurgitation.

Platelet-to-Albumin Ratio Linked to Disease Activity in Early Rheumatoid Arthritis

Platelet-to-albumin ratio linked to disease activity in early rheumatoid arthritis, with a notable threshold effect.

Brain Changes Linked to Pain in Women with Endometriosis

Women with endometriosis show unique neurobiological changes in the brain, distinct from those in women with chronic pelvic pain without endometriosis.

Three-Cycle Chemotherapy Proves Effective for High-Risk Retinoblastoma

A recent trial found that three cycles of CEV chemotherapy are as effective as six in treating high-risk unilateral retinoblastoma after enucleation.

High Rates of Kinesiophobia in Peritoneal Dialysis Patients

Kinesiophobia affects 69% of peritoneal dialysis patients, influenced by factors like fatigue and coping strategies.

WHO Lists Top Endemic Pathogens Needing Urgent Vaccines

The World Health Organization (WHO) has published a new list of 17 high-priority pathogens for vaccine research and development.

Increased Psoriasis Risk in Patients with Cancer

Patients with cancer treated with immune checkpoint inhibitors face a twofold increased risk of developing psoriasis